Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T80753 |
YL-365
|
||
YL-365为GPR34受体拮抗剂,适用于疼痛及肿瘤研究领域。 | |||
T38223 |
N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide
|
||
N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide binds to the cannabinoid 1 (CB1) receptor with a Ki value of 365 nM in a radioligand binding assay using rat brain homogenate. It has an EC50 value of 698 nM for the peroxisome proliferator-activated receptor α (PPARα) in a luciferase reporter assay and, in rats, it decreases food intake. It does not inhibit fatty acid amide hydrolase (FAAH). |